Pantec Biosolutions

Executive Summary

Pantec Biosolutions AG is a Swiss-based company specializing in 2 and 3 micron laser technology for medical and industrial applications. Founded in 2008 and headquartered in Lugano, the company offers engineering and design services under ISO 13485 certification, from concept to zero-series production. Its core technology is poised to enable innovative drug delivery solutions, particularly in transdermal and microneedle-based systems where precise micro-poration can enhance bioavailability. While the company operates in the competitive drug delivery market, its focus on high-precision lasers and ISO-certified manufacturing capabilities positions it as a potential partner for pharmaceutical and medical device firms seeking advanced delivery mechanisms. Pantec's private status limits public financial visibility, but its specialized expertise and early-stage collaborations could drive near-term growth.

Upcoming Catalysts (preview)

• Q4 2026Partnership with a major pharmaceutical company for laser-based drug delivery system20% success
• Q3 2026Release of next-generation 2-micron laser platform for medical aesthetics40% success
• Q2 2027Receipt of additional ISO certifications or CE marking for new industrial laser systems60% success